[Industrial Securities Pharma] TINAVI Plans to Issue Shares to Acquire Controlling Stake in Shanghai MicroPort Orthopedics

English summary

TINAVI is planning to purchase a 62% controlling stake in Shanghai MicroPort Orthopedics Medical Technology Co., Ltd. by issuing shares, and also plans to raise supporting funds. This transaction will help the company improve its orthopedic product matrix, build a comprehensive solution of 'robots + implants + consumables + services,' and accelerate the internationalization of the listed company. Target company: In 2025 and the first quarter of 2026, its operating revenue was 1.573 billion yuan and 359 million yuan, respectively, with net profit attributable to the parent of -105 million yuan and -40 million yuan, respectively. The target company mainly engages in knee and hip reconstruction business in overseas markets such as the US, Japan, and Europe, ranking among the top 10 in global market share of joint implants. Share issuance: The issuance price is 14.36 yuan per share. The total amount of supporting funds to be raised shall not exceed 100% of the transaction price of the assets purchased by issuing shares in this transaction, and the number of shares issued shall not exceed 30% of the total share capital of the listed company before the issuance of shares for supporting funds. Transaction price: The total consideration of this transaction and the consideration to be paid to each transaction counterparty have not yet been determined. ...